ArticleInternational journal of clinical and experimental medicine2015
Association between IL-10 polymorphisms (-1082A/G, -592A/C and -819T/C) and oral cancer risk.
Article in International journal of clinical and experimental medicine, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers, 2 of them syntheses that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
4 citing papers in PubMed, 2 syntheses or guidelines pooled it, 8 citations in OpenAlex.
- Association between interleukin-10 gene polymorphisms and risk of oral carcinoma: A meta-analysis.Histology and histopathology · 2020Pooled it
- Association of interleukin 10 rs1800896 polymorphism with susceptibility to breast cancer: a meta-analysis.The Journal of international medical research · 2020Pooled it
- Impacts of Interleukin-10 Promoter Genotypes on Prostate Cancer.Life (Basel, Switzerland) · 2024Article
- Association of Interleukin-10 Genotypes and Oral Cancer Susceptibility in Selected Malaysian Population: A Case- Control StudyAsian Pacific journal of cancer prevention : APJCP · 2019Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors at 2 institutions in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Interleukin-10 (IL-10) is likely to be closely correlated with the outbreak and progression of cancers though aiding tumors to free from the immune response. In previous studies, several polymorphisms sites including -1082A/G, -592A/C and -819T/C in the promoter region of IL-10 gene were proved to be involved in oral cancer. The purpose of this study was to further explore this association via a meta-analysis. There were four publications with 3783 cases and 4245 controls retrieved though electronic databases. The association among three IL-10 polymorphisms sites was estimated by summary odds ratios (ORs) and 95% confidence intervals (95% CIs) which were calculated using fixed-effect model. Subgroup analysis by ethnicity (Asian or Caucasian) was also performed for the analysis of IL-10-1082A/G polymorphism (three studies in Asians and one study in Caucasian). As a result, we found a moderately increased risk which was related to IL-10-1082A/G polymorphism in oral cancer under all the five contrasts [GG vs. AA: OR (95% CI)=2.95 (1.94-4.48); GG+AG vs. AA: OR (95% CI)=1.59 (1.35-1.86); GG vs. AG+AA: OR (95% CI)=2.59 (1.71-3.94); Allele G vs. Allele A: OR (95% CI)=1.68 (1.46-1.94); AG vs. AA: OR (95% CI)=1.53 (1.29-1.81)]. Additionally, the increased risk of oral cancer was also observed in Asians and Caucasians. However, the pooled data indicated that IL-10 -592A/C and -819T/C polymorphisms sites had no relationship with oral cancer risk. Taken together, the IL-10-1082A/G polymorphism site may act as a risk factor in oral cancer, and this issue still needs to be further verified.
Indexed as
Identifiers
26550242PMC4612927W2195270899What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.